In our large real‐world population of 1752 PMF and SMF subjects, median Hb value at diagnosis was 11.4 g/dL, and 31.9% of subjects presented CTCAE grade 2 or 3/4 anemia. This evidence concerns the gene GSTM1 and anemia (phenotype).